Seasonal affective disorder (SAD) is a mood disorder subset in which people who have normal mental health throughout most of the year exhibit depressive symptoms at the same time each year, most commonly in the winter. Common symptoms include sleeping too much, having little to no energy, and overeating. The condition in the summer can include heightened anxiety.
In 2018, the global Seasonal Affective Disorder Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Seasonal Affective Disorder Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Seasonal Affective Disorder Therapeutics development in United States, Europe and China.
The key players covered in this study
Allergan
Pfizer
Roche
Eli Lily
GlaxoSmithKline
Teva Pharmaceuticals
Bausch Health Companies
Mylan
Sanofi
Novartis
Johnson & Johnson
Koninklijke Philips
Beurer GmbH
Lucimed (Luminette)
Market segment by Type, the product can be split into
Light Therapy (Phototherapy)
Medication
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Seasonal Affective Disorder Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Seasonal Affective Disorder Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Seasonal Affective Disorder Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Light Therapy (Phototherapy)
1.4.3 Medication
1.4.4 Others
1.5 Market by Application
1.5.1 Global Seasonal Affective Disorder Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Seasonal Affective Disorder Therapeutics Market Size
2.2 Seasonal Affective Disorder Therapeutics Growth Trends by Regions
2.2.1 Seasonal Affective Disorder Therapeutics Market Size by Regions (2014-2025)
2.2.2 Seasonal Affective Disorder Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Seasonal Affective Disorder Therapeutics Market Size by Manufacturers
3.1.1 Global Seasonal Affective Disorder Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Seasonal Affective Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Seasonal Affective Disorder Therapeutics Key Players Head office and Area Served
3.3 Key Players Seasonal Affective Disorder Therapeutics Product/Solution/Service
3.4 Date of Enter into Seasonal Affective Disorder Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Seasonal Affective Disorder Therapeutics Market Size by Type (2014-2019)
4.2 Global Seasonal Affective Disorder Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Seasonal Affective Disorder Therapeutics Market Size (2014-2019)
5.2 Seasonal Affective Disorder Therapeutics Key Players in United States
5.3 United States Seasonal Affective Disorder Therapeutics Market Size by Type
5.4 United States Seasonal Affective Disorder Therapeutics Market Size by Application
6 Europe
6.1 Europe Seasonal Affective Disorder Therapeutics Market Size (2014-2019)
6.2 Seasonal Affective Disorder Therapeutics Key Players in Europe
6.3 Europe Seasonal Affective Disorder Therapeutics Market Size by Type
6.4 Europe Seasonal Affective Disorder Therapeutics Market Size by Application
7 China
7.1 China Seasonal Affective Disorder Therapeutics Market Size (2014-2019)
7.2 Seasonal Affective Disorder Therapeutics Key Players in China
7.3 China Seasonal Affective Disorder Therapeutics Market Size by Type
7.4 China Seasonal Affective Disorder Therapeutics Market Size by Application
8 Japan
8.1 Japan Seasonal Affective Disorder Therapeutics Market Size (2014-2019)
8.2 Seasonal Affective Disorder Therapeutics Key Players in Japan
8.3 Japan Seasonal Affective Disorder Therapeutics Market Size by Type
8.4 Japan Seasonal Affective Disorder Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Seasonal Affective Disorder Therapeutics Market Size (2014-2019)
9.2 Seasonal Affective Disorder Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Seasonal Affective Disorder Therapeutics Market Size by Type
9.4 Southeast Asia Seasonal Affective Disorder Therapeutics Market Size by Application
10 India
10.1 India Seasonal Affective Disorder Therapeutics Market Size (2014-2019)
10.2 Seasonal Affective Disorder Therapeutics Key Players in India
10.3 India Seasonal Affective Disorder Therapeutics Market Size by Type
10.4 India Seasonal Affective Disorder Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Seasonal Affective Disorder Therapeutics Market Size (2014-2019)
11.2 Seasonal Affective Disorder Therapeutics Key Players in Central & South America
11.3 Central & South America Seasonal Affective Disorder Therapeutics Market Size by Type
11.4 Central & South America Seasonal Affective Disorder Therapeutics Market Size by Application
12 International Players Profiles
12.1 Allergan
12.1.1 Allergan Company Details
12.1.2 Company Description and Business Overview
12.1.3 Seasonal Affective Disorder Therapeutics Introduction
12.1.4 Allergan Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
12.1.5 Allergan Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Seasonal Affective Disorder Therapeutics Introduction
12.2.4 Pfizer Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Seasonal Affective Disorder Therapeutics Introduction
12.3.4 Roche Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
12.3.5 Roche Recent Development
12.4 Eli Lily
12.4.1 Eli Lily Company Details
12.4.2 Company Description and Business Overview
12.4.3 Seasonal Affective Disorder Therapeutics Introduction
12.4.4 Eli Lily Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
12.4.5 Eli Lily Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Company Details
12.5.2 Company Description and Business Overview
12.5.3 Seasonal Affective Disorder Therapeutics Introduction
12.5.4 GlaxoSmithKline Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
12.5.5 GlaxoSmithKline Recent Development
12.6 Teva Pharmaceuticals
12.6.1 Teva Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Seasonal Affective Disorder Therapeutics Introduction
12.6.4 Teva Pharmaceuticals Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
12.6.5 Teva Pharmaceuticals Recent Development
12.7 Bausch Health Companies
12.7.1 Bausch Health Companies Company Details
12.7.2 Company Description and Business Overview
12.7.3 Seasonal Affective Disorder Therapeutics Introduction
12.7.4 Bausch Health Companies Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
12.7.5 Bausch Health Companies Recent Development
12.8 Mylan
12.8.1 Mylan Company Details
12.8.2 Company Description and Business Overview
12.8.3 Seasonal Affective Disorder Therapeutics Introduction
12.8.4 Mylan Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
12.8.5 Mylan Recent Development
12.9 Sanofi
12.9.1 Sanofi Company Details
12.9.2 Company Description and Business Overview
12.9.3 Seasonal Affective Disorder Therapeutics Introduction
12.9.4 Sanofi Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
12.9.5 Sanofi Recent Development
12.10 Novartis
12.10.1 Novartis Company Details
12.10.2 Company Description and Business Overview
12.10.3 Seasonal Affective Disorder Therapeutics Introduction
12.10.4 Novartis Revenue in Seasonal Affective Disorder Therapeutics Business (2014-2019)
12.10.5 Novartis Recent Development
12.11 Johnson & Johnson
12.12 Koninklijke Philips
12.13 Beurer GmbH
12.14 Lucimed (Luminette)
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
